Hyperfine enrolls 100th patient in neurology study

Portable MRI developer Hyperfine has enrolled the 100th patient in its NEURO PMR (Neurological Evaluation in the Office with Portable MRI) study.

The company reached this milestone 16 weeks after the study began, it said. The research is being conducted at DENT Neurologic Institute and Texas Neurology; all participating patients have been scanned on Hyperfine's Swoop system, which features its OptiveAI software. 

The firm expects to announce results in early 2026.